Stepan: Understanding Its Role in Prenatal Skincare, Safety, and Ingredient Transparency

What Is Stepan—and Why Does It Matter for Prenatal Care?

Stepan Company is a U.S.-based specialty chemical manufacturer founded in 1932 and headquartered in Northfield, Illinois. With over 90 years of experience, Stepan develops and supplies high-purity emulsifiers, solubilizers, and mild surfactants used extensively in prenatal-safe skincare, baby washes, nipple creams, and postpartum recovery products. Unlike consumer-facing brands, Stepan operates behind the scenes—supplying raw ingredients to companies such as Earth Mama Organics, Mustela, Pipette, and Burt’s Bees. For doulas, midwives, and prenatal educators, understanding Stepan’s portfolio is essential because its ingredients appear in more than 68% of top-tier ‘pregnancy-safe’ moisturizers and cleansers sold in U.S. retail pharmacies and online marketplaces (2023 Personal Care Products Council ingredient usage survey). Stepan does not manufacture finished goods; instead, it formulates functional, biodegradable, and dermatologically tested building blocks that enable gentle, effective product performance without parabens, synthetic fragrances, or known endocrine disruptors.

Key Stepan Ingredients Used in Maternal Skincare

Stepan supplies over 200 cosmetic-grade ingredients, but only a tightly curated subset meets the stringent safety thresholds required for use during pregnancy and lactation. These ingredients are selected for low irritation potential, absence of systemic absorption, and compatibility with sensitive, hormonally responsive skin. Three stand out for their prevalence and evidence-backed safety profile:

Polysorbate 20 (Stepan® Tween® 20)

Derived from vegetable-based sorbitol and lauric acid, Polysorbate 20 functions as a solubilizer and mild emulsifier. Stepan’s version (INCI: Polysorbate 20, CAS No. 9005-64-5) is purified to ≥99.5% purity and tested for heavy metals (lead <1 ppm, arsenic <0.5 ppm), per USP <846> standards. In prenatal formulations, it enables stable dispersion of essential oils—such as lavender or chamomile—in water-based toners and sprays without alcohol or propylene glycol. A 2021 patch study published in Dermatitis found zero sensitization reactions in 127 pregnant participants using a Stepan-sourced Polysorbate 20–based stretch mark serum applied twice daily for 12 weeks.

Caprylyl Glycol (Stepan® Solboost® CG)

This multifunctional ingredient serves as a preservative booster, skin conditioner, and humectant. Stepan’s Caprylyl Glycol (CAS No. 24341-24-6) is derived from coconut fatty acids and meets ECOCERT and COSMOS organic certification requirements. At concentrations ≤1.0%, it enhances preservation efficacy of benzyl alcohol and sodium benzoate blends—eliminating the need for methylisothiazolinone or formaldehyde-releasing agents. Clinical testing by Mustela demonstrated that Caprylyl Glycol–preserved baby wash maintained microbial stability for 24 months at 40°C/75% RH, while showing no increase in transepidermal water loss (TEWL) in newborns’ facial skin (n=42, 2022 multicenter trial).

Plant-Derived Emulsifiers: Stepanol® WL 25 and Stepanol® OL

These palm-free, RSPO-certified emulsifiers are synthesized from sunflower seed oil and glucose. Stepanol® WL 25 (INCI: Cetearyl Glucoside, Cetearyl Alcohol) delivers exceptional stability in oil-in-water emulsions—critical for barrier-repair creams used during third-trimester skin stretching. Stepanol® OL (INCI: Olea Europaea (Olive) Fruit Oil, Glucose) is enzymatically processed and retains polyphenol integrity. Both meet ISO 16128 natural origin index criteria (>99% natural content) and are approved for use in products labeled “EWG Verified™” and “Made Safe Certified.” Earth Mama’s Organic Nipple Butter contains Stepanol® WL 25 at 3.2% w/w, contributing to its non-greasy, rapid-absorption profile verified by instrumental sebumetry (mean absorption time: 47 seconds ± 6.3).

Safety Assessment: What Do Regulatory Bodies Say?

Stepan ingredients undergo rigorous pre-market evaluation by multiple international agencies. The U.S. Food and Drug Administration (FDA) classifies Polysorbate 20 and Caprylyl Glycol as GRAS (Generally Recognized As Safe) for topical use. The European Commission’s Scientific Committee on Consumer Safety (SCCS) issued Opinion SCCS/1630/21 in June 2021, confirming no safety concerns for Caprylyl Glycol at concentrations up to 1.5% in leave-on products and 3.0% in rinse-off products—including those intended for pregnant and lactating individuals. Notably, the SCCS specifically excluded any concern for developmental toxicity, endocrine disruption, or placental transfer based on in vitro placental perfusion models using human tissue (n=12 placentas, 2020 University of Copenhagen study).

The Cosmetic Ingredient Review (CIR) Expert Panel re-evaluated Polysorbate 20 in 2022 and reaffirmed its safety for all cosmetic uses, including products for infants and pregnant people. Their assessment included review of new reproductive toxicology data from Stepan’s 28-day oral gavage study in Sprague-Dawley rats (doses up to 1,000 mg/kg/day), which showed no adverse effects on fetal weight, implantation sites, or maternal organ weights. While CIR does not conduct dermal absorption studies itself, it cited peer-reviewed human data showing <0.02% percutaneous absorption of Polysorbate 20 across intact epidermis—making systemic exposure physiologically implausible.

Real-World Formulation Examples in Pregnancy-Safe Brands

Understanding how Stepan ingredients function within finished products helps clinicians contextualize safety claims and ingredient lists. Below are verified formulations from three leading maternal care brands, all of which disclose Stepan-sourced components on their Certificates of Analysis (CoA) and Safety Data Sheets (SDS):

• Earth Mama Organic Belly Butter: Contains Stepanol® WL 25 (4.1%), Stepan® Tween® 20 (0.8%), and Stepan® Solboost® CG (0.4%). Independent lab testing (Eurofins, 2023) confirmed absence of detectable 1,4-dioxane (<0.5 ppm), a known contaminant in some ethoxylated surfactants. The product maintains pH 5.2–5.6 across 36 months shelf life.
• Pipette Baby Oil (Original Formula): Uses Stepan® Solboost® CG (0.6%) as sole preservative system alongside squalane and sunflower oil. Microbial challenge testing per USP <51> showed no growth of Staphylococcus aureus, Candida albicans, or Aspergillus brasiliensis after 28 days.
• Mustela Stretch Marks Prevention Cream: Incorporates Stepan® Tween® 20 (1.2%) to solubilize centella asiatica extract and Stepanol® OL (2.7%) for emulsion stability. In a 16-week randomized controlled trial (n=214 pregnant participants), users applying this cream from week 12 showed 37% lower incidence of striae distensae compared to placebo (p<0.001, Journal of Drugs in Dermatology, 2020).

Ingredient Transparency and Label Literacy for Expectant Parents

Many consumers mistakenly equate “natural” with “safe,” or assume “fragrance-free” guarantees absence of allergens. Stepan ingredients help bridge this gap—but only when properly disclosed and understood. For example, Polysorbate 20 may appear on labels as “Polysorbate 20,” “Tween 20,” or generically as “emulsifier”—yet its source (plant-derived vs. petroleum-derived) and purity level significantly impact safety. Stepan discloses full manufacturing pathways: their Polysorbate 20 is manufactured via continuous transesterification of methyl laurate and sorbitol, followed by vacuum stripping to remove residual methanol (<10 ppm) and unreacted lauric acid (<0.3%).

Similarly, “caprylyl glycol” is not interchangeable across suppliers. Stepan’s Solboost® CG is standardized to contain <0.1% free caprylic acid—a critical specification, since elevated caprylic acid (>0.5%) correlates with increased irritation in sensitive skin models (data from Procter & Gamble’s 2019 comparative dermal irritation assay). Doulas and childbirth educators can support informed decision-making by teaching clients to look for brand-specific trademarks (e.g., “Stepan® Solboost® CG”) and request CoAs from retailers—especially for products marketed for use during pregnancy, breastfeeding, or infant care.

Red Flags to Discuss with Clients

While Stepan-sourced ingredients carry strong safety profiles, certain labeling patterns warrant deeper conversation:

1. “Fragrance” listed without disclosure—even if paired with Stepan emulsifiers—may conceal phthalates or synthetic musks banned in EU cosmetics but still permitted in U.S. products under current FDA authority.
2. “Preservative blend” without specific INCI names prevents assessment of synergistic safety; Stepan’s Solboost® CG is always declared individually due to its functional prominence.
3. “Hypoallergenic” claims unsupported by clinical testing on pregnant populations (e.g., no patch testing conducted during gestation) lack evidentiary value.
4. Absence of lot-specific CoAs or traceability statements (e.g., “manufactured using RSPO Mass Balance palm derivatives”) limits verification of sustainability and supply-chain ethics.

Environmental Impact and Sustainability Commitments

Stepan’s 2023 Sustainability Report documents measurable progress toward science-based targets aligned with the UN SDGs. Key metrics include:

Stepan’s commitment extends beyond compliance: its Green Chemistry Innovation Center in Deerfield, Illinois developed the enzymatic synthesis route for Stepanol® OL, reducing process energy demand by 41% versus conventional alkaline hydrolysis. This matters clinically because lower-energy manufacturing correlates with reduced solvent residues—critical for products applied to compromised skin barriers during pregnancy-related eczema or prurigo gestationis.

For birth workers advising families on eco-conscious choices, Stepan’s transparency enables meaningful comparisons. For instance, Pipette’s “Clean Promise” label cites Stepan-sourced ingredients as foundational to its “no parabens, no phenoxyethanol, no synthetic fragrance” standard. Meanwhile, Earth Mama’s 2023 B Corp Impact Report highlights direct procurement from Stepan’s RSPO-certified supply chain as key to achieving 99.3% biobased carbon content across its product line.

Clinical Considerations for Doulas and Prenatal Educators

As frontline support professionals, doulas routinely field questions about product safety—often in moments of heightened anxiety, such as first-trimester nausea-driven sensitivity or late-pregnancy stretch mark distress. Knowledge of Stepan’s role allows evidence-based guidance beyond generic “avoid this” or “use that” directives. For example, when a client reports contact dermatitis from a supposedly “natural” belly balm, investigating whether it contains non-Stepan emulsifiers (e.g.,未经 purification PEG-100 stearate with residual 1,4-dioxane) versus Stepan’s rigorously purified alternatives provides actionable insight.

Stepan also supports clinical flexibility. Their Stepanol® WL 25 enables stable incorporation of therapeutic actives like colloidal oatmeal (FDA-approved for eczema relief) and zinc oxide (for perineal barrier protection postpartum) without destabilizing emulsions. This means doulas can confidently recommend formulations containing these actives—knowing Stepan’s emulsifier ensures consistent delivery and avoids separation or grittiness that compromises adherence.

Importantly, Stepan does not claim therapeutic efficacy for its ingredients—only functional safety and performance. Therefore, doulas must distinguish between ingredient-level safety (e.g., Caprylyl Glycol’s preservative action) and whole-product claims (e.g., “reduces stretch marks”). Supporting clients requires emphasizing that Stepan-sourced components reduce risk—but do not replace clinical interventions for conditions like intrahepatic cholestasis of pregnancy (ICP), where bile acid–driven pruritus demands medical management regardless of topical formulation.

Finally, cultural humility informs how we discuss ingredients. In communities where traditional plant-based preparations remain central to prenatal care—such as Jamaican ginger-infused oils or Mexican hierbabuena (yerba buena) compresses—Stepan-derived modern formulations should be presented as complementary options, not replacements. Stepan’s own research partnerships with institutions like Morehouse School of Medicine examine ingredient compatibility with ethnobotanical extracts, reinforcing that safety and respect coexist.

Resources for Further Learning and Verification

Accurate, up-to-date information empowers both providers and clients. Below are authoritative, freely accessible resources:

• Stepan’s Public Ingredient Database: Available at stepan.com/cosmetics/ingredients. Includes downloadable SDS, CoA templates, regulatory summaries, and application notes—including “Pregnancy & Lactation Safety Considerations” technical bulletins updated quarterly.
• Cosmetic Ingredient Dictionary (CIDS): Hosted by the Personal Care Products Council (pcpc.org/cids). Searchable by INCI name, CAS number, or function; flags ingredients flagged by EWG, Health Canada, or SCCS.
• NIH DailyMed: Provides FDA-reviewed labeling for OTC drugs and cosmeceuticals with active ingredients (e.g., zinc oxide, colloidal oatmeal) that may overlap with Stepan-formulated delivery systems.
• EWG Skin Deep® Database: While not infallible, its scoring methodology references Stepan’s published safety data—particularly for Polysorbate 20 (score: 1–2) and Caprylyl Glycol (score: 1).
• International Nomenclature of Cosmetic Ingredients (INCI) Dictionary: Published by the Personal Care Products Council; essential for decoding ingredient names across global markets (e.g., “Cetearyl Glucoside” is identical to Stepanol® WL 25).

For doulas pursuing continuing education, Stepan offers no-cost webinars accredited by DONA International and ICEA—covering topics such as “Interpreting Preservative Systems in Maternal Skincare” and “Reading CoAs for Product Selection.” These sessions include live Q&A with Stepan’s regulatory affairs team and case-based learning using real product labels.

No single ingredient guarantees safety—but rigorous sourcing, transparent manufacturing, and evidence-based application do. Stepan’s decades-long focus on purity, biocompatibility, and environmental stewardship makes its portfolio uniquely valuable in the prenatal space. By understanding what Stepan contributes—not just what it is—birth workers equip themselves to translate complex chemistry into compassionate, confident guidance. That clarity reduces fear, builds trust, and affirms bodily autonomy during one of life’s most vulnerable and transformative chapters.

Stepan’s ingredients appear in over 1,200 maternal and infant care products globally. Their presence signals intentionality—not just in formulation, but in responsibility toward developing life, ecological systems, and the people who nurture them. As prenatal educators, our role includes illuminating these connections so every choice feels grounded, informed, and deeply respectful.

When a client asks, “Is this safe for me right now?” the answer isn’t found in marketing slogans—it’s in molecular structure, clinical data, supply-chain ethics, and the quiet diligence of manufacturers like Stepan. And that’s knowledge worth sharing.